“Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study”, Radiol Oncol, vol. 57, no. 3, pp. 405–410, Sep. 2023, Accessed: Sep. 24, 2026. Available: https://radioloncol.com/index.php/ro/article/view/4122